Olopatadine-d6 (hydrochloride)

Olopatadine-d6 (hydrochloride)

• UNSPSC Description: Olopatadine-d6 (ALO4943A-d6; KW4679-d6) hydrochloride is deuterium-labeled Olopatadine (hydrochloride) (HY-B0426A)[1].
• Target Antigen: Endogenous Metabolite; Histamine Receptor; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: GPCR/G Protein;Immunology/Inflammation;Metabolic Enzyme/Protease;Neuronal Signaling;Others
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Smiles: O=C(O)CC1=CC=C(C/2=C1)OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C3C2=C\CCN(C)C.Cl
• Molecular Weight: 379.91
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported